Nuvectis Pharma | 4: Statement of changes in beneficial ownership of securities-Officer BENTSUR RON
Nuvectis Pharma | 10-K: Annual report
Nuvectis Pharma | 8-K: Current report
Nuvectis Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Charles Mosseri-Marlio(15%)
Nuvectis Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Pontifax VI G.P. L.P.(5.3%),Pontifax Management 4 G.P. (2015) Ltd.(5.3%), etc.
Nuvectis Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Enrique Poradosu(8.7%)
Nuvectis Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Shay Shemesh(8.6%)
Nuvectis Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Thomas Peters(5.2%)
Nuvectis Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Poradosu Enrique
Nuvectis Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Shemesh Shay
Nuvectis Pharma | 8-K: Nuvectis Pharma, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights
Nuvectis Pharma: Q3 2023 Earnings Report
Nuvectis Pharma | 4: Statement of changes in beneficial ownership of securities-Officer BENTSUR RON
Nuvectis Pharma | 4: Statement of changes in beneficial ownership of securities-Officer BENTSUR RON
Nuvectis Pharma | 4: Statement of changes in beneficial ownership of securities-Officer BENTSUR RON
Nuvectis Pharma | 8-K: Current report
Nuvectis Pharma | 8-K: Current report
Nuvectis Pharma | 4: Statement of changes in beneficial ownership of securities-Officer BENTSUR RON
Nuvectis Pharma | 4: Statement of changes in beneficial ownership of securities-Officer BENTSUR RON
Nuvectis Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
No Data